389 related articles for article (PubMed ID: 8813924)
1. Sildenafil, a novel effective oral therapy for male erectile dysfunction.
Boolell M; Gepi-Attee S; Gingell JC; Allen MJ
Br J Urol; 1996 Aug; 78(2):257-61. PubMed ID: 8813924
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men.
Price DE; Gingell JC; Gepi-Attee S; Wareham K; Yates P; Boolell M
Diabet Med; 1998 Oct; 15(10):821-5. PubMed ID: 9796881
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
Conti CR; Pepine CJ; Sweeney M
Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
[TBL] [Abstract][Full Text] [Related]
4. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
Goldstein I; Lue TF; Padma-Nathan H; Rosen RC; Steers WD; Wicker PA
N Engl J Med; 1998 May; 338(20):1397-404. PubMed ID: 9580646
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.
DeBusk RF; Pepine CJ; Glasser DB; Shpilsky A; DeRiesthal H; Sweeney M
Am J Cardiol; 2004 Jan; 93(2):147-53. PubMed ID: 14715338
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.
Fava M; Nurnberg HG; Seidman SN; Holloway W; Nicholas S; Tseng LJ; Stecher VJ
J Clin Psychiatry; 2006 Feb; 67(2):240-6. PubMed ID: 16566619
[TBL] [Abstract][Full Text] [Related]
8. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial.
McCullough AR; Levine LA; Padma-Nathan H
J Sex Med; 2008 Feb; 5(2):476-84. PubMed ID: 18086170
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.
Morales A; Gingell C; Collins M; Wicker PA; Osterloh IH
Int J Impot Res; 1998 Jun; 10(2):69-73; discussion 73-4. PubMed ID: 9647940
[TBL] [Abstract][Full Text] [Related]
10. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction.
Meuleman E; Cuzin B; Opsomer RJ; Hartmann U; Bailey MJ; Maytom MC; Smith MD; Osterloh IH
BJU Int; 2001 Jan; 87(1):75-81. PubMed ID: 11121996
[TBL] [Abstract][Full Text] [Related]
11. Duration of action of sildenafil citrate in men with erectile dysfunction.
Gingell C; Sultana SR; Wulff MB; Gepi-Attee S
J Sex Med; 2004 Sep; 1(2):179-84. PubMed ID: 16422972
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil (Viagra) in the treatment of male erectile dysfunction in Nairobi.
Magoha GA
East Afr Med J; 2000 Feb; 77(2):76-9. PubMed ID: 10774079
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.
Fink HA; Mac Donald R; Rutks IR; Nelson DB; Wilt TJ
Arch Intern Med; 2002 Jun; 162(12):1349-60. PubMed ID: 12076233
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
[TBL] [Abstract][Full Text] [Related]
15. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect.
Musicki B; Champion HC; Becker RE; Kramer MF; Liu T; Sezen SF; Burnett AL
J Urol; 2005 Oct; 174(4 Pt 1):1493-6. PubMed ID: 16145478
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
Boolell M; Allen MJ; Ballard SA; Gepi-Attee S; Muirhead GJ; Naylor AM; Osterloh IH; Gingell C
Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial.
Gopalakrishnan R; Jacob KS; Kuruvilla A; Vasantharaj B; John JK
Am J Psychiatry; 2006 Mar; 163(3):494-9. PubMed ID: 16513872
[TBL] [Abstract][Full Text] [Related]
19. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury.
Maytom MC; Derry FA; Dinsmore WW; Glass CA; Smith MD; Orr M; Osterloh IH
Spinal Cord; 1999 Feb; 37(2):110-6. PubMed ID: 10065749
[TBL] [Abstract][Full Text] [Related]
20. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
Ströberg P; Murphy A; Costigan T
Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
